Therapeutic disruption of CONNEXIN43-mediated microtubule regulation to target glioblastoma cancer stem cells
Ended Project Grant Awarded Last action
- Award ID
- R41CA217503
- Recipient
-
Acomhal Research, Inc. UEI QCZ3GLF8WNP5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $224,994
Award facts
- Assistance listing
- 93.353 21st Century Cures Act - Beau Biden Cancer Moonshot
- Completion date
- Originally
- Place of performance
- Roanoke, VA 24016, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$5 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $224,999 |
Quick answers
Who received award R41CA217503?
R41CA217503 was awarded to Acomhal Research, Inc. by National Cancer Institute (National Institutes of Health) on September 1, 2017.
How much is award R41CA217503 worth?
$224,994 has been obligated on R41CA217503.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award